This medical professional's nonchalance about the difference is in pretty stark contradiction to your bizarre claim that they "aren't doing even shallow research into nutrition". There's a million possible reasons they may have decided not to optimize solely for bio-availablility, just as my doctor did.
Even in general though, I don't see why the only thing to optimize for is as much bioavailability as possible. People care about things like cost too. (Though this opinion of mine is a lot less strong than my reaction to your initial claim)
Is that the primary difference?
That there's this much nuance just with this one ingredient is a microcosm of the overall flaw in Soylent's approach.
Optimizing for just the legible dimensions of a poorly understood domain will not result in good outcomes.
For mealsquares we take consilience seriously and combine the inside and outside view (see: reference class forecasting) on human nutrition to try to establish reasonable confidence intervals around nutrition models, and even then we aren't stupid enough to think or claim that mealsquares are just as good as fish, fruit, and vegetables.
Thank you. This one sentence can replace all my responses to the original post.
"ergocalciferol should not be regarded as a nutrient suitable for supplementation or fortification."
D2 and D3 are metabolized so differently that they result in the "production of unique biologically active metabolites."
Ergocalciferol is the version used in the Soylent powder, while the bottled version doesn't even deign to inform the consumer what they are getting (it just says Vitamin D)
The fact that this problem exists and has existed for years with many of their ingredients indicates that they aren't even doing shallow research into nutrition.
(https://www.MealSquares.com try to provide multiple sources of all micronutrients from different food groups)